Zealand Pharma

Director's Dealing • Apr 19, 2024

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Krisko Nygaard
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	854
d)	Aggregated information
	- Aggregated volume - Price	854 DKK 510,692.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Steensberg
2.	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/Amend ment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc tion monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Restricted Share Units Description of the financial instrument, type of instru ment
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Share Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	25,626
d)	Aggregated information - Aggregated volume - Price	25,626 DKK 15,324,348.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Anneline Nansen
2.	Reason for the notification
a)	Position/status		Employee elected member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	854
d)	Aggregated information
	- Aggregated volume - Price	854 DKK 510,692.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Bernadette Connaughton
2.	Reason for the notification
a)	Position/status		Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
	Aggregated information
d)	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Elaine Sullivan
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
d)	Aggregated information
	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Enrique Conterno Martinelli
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name		Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
d)	Aggregated information
	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Frederik Barfoed Beck
2.	Reason for the notification
a)	Position/status		Employee elected member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	854
d)	Aggregated information
	- Aggregated volume - Price	854 DKK 510,692.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Henriette Wennicke
2.	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Share Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Share Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	8,008
d)	Aggregated information
	- Aggregated volume - Price	8,008 DKK 9,577,568.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jeffrey Berkowitz
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
d)	Aggregated information
	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kirsten A. Drejer
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
d)	Aggregated information
	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Leonard Kruimer
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instru ment		Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	2,135
d)	Aggregated information
	- Aggregated volume - Price	2,135 DKK 1,276,730.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.		Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ludovic Tranholm Otterbein
2.	Reason for the notification
a)	Position/status		Employee elected member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	854
d)	Aggregated information
	- Aggregated volume	854
	- Price	DKK 510,692.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Martin Nicklasson
2.	Reason for the notification
a)	Position/status	Chairman of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amend ment	Initial notification
3.	tion monitor	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Stock Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 598	4,271
d)	Aggregated information
	- Aggregated volume - Price	4,271 DKK 2,554,058.00
e)	Date of the transaction	19 April 2024
f)	Place of the transaction	Outside the market